PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsiritis
MeSH D007500 - iritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007499:Iris diseases
0 Companies
0 Drugs
Success rate
D014606:Anterior uveitis
$
Success rate
D007500: 
Iritis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDexamethasone Dexamethasone  1990-08-31   
PadagisDexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1989-07-31   
Dexamethasone, Tobramycin Tobramycin Dexamethasone  2022-02-11   
MylanDexamethasone Dexamethasone  2008-08-29   
SandozDexamethasone Dexamethasone  1985-01-16   
Dexamethasone, Neomycin, Polymyxin b Maxitrol  1984-05-22   
Dexamethasone, Ciprofloxacin Ciprodex 2025-06-04 2003-07-18   
Dexamethasone, Tobramycin Tobradex  1988-08-18   
AbbVieDexamethasone Ozurdex 2023-01-09 2009-06-17 $486 M Q2/24-Q1/25 
NovartisDexamethasone, Neomycin, Polymyxin b Dexacidin  1984-10-29   
Dexamethasone, Tobramycin Tobradex  1988-09-28   
WyethDexamethasone Dexamethasone  1982-01-01   
UCBDexamethasone Dexacort  1982-01-01   
AlpharmaDexamethasone Dexamethasone  1986-10-10   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
4/4
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use